1.
MYCOSES : Surveillance épidémiologique en Belgique 2016-2017
2.
3.
Time between symptom onset, hospitalisation and recovery or death : statistical analysis of Belgian COVID-19 patients
4.
5.
6.
7.
8.
9.
Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients
Estimates of the HIV undiagnosed population in Belgium reveals higher prevalence for MSM with foreign nationality and for geographic areas hosting big cities
Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium – Authors' reply
Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium
Insights into the association of ACEIs/ARBs use and COVID-19 prognosis : a multistate modelling study of nationwide hospital surveillance data from Belgium
Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients.
Prevalence estimates of genital Chlamydia trachomatis infection in Belgium: results from two cross-sectional studies.
Prevalence estimates of genital Chlamydia trachomatis infection in Belgium: results from two cross-sectional studies